Eargo 5 vs Resound Vivia 9 60S microRIE

The Eargo 5 is a premium-priced OTC hearing aid ($1,450) that earns a B grade with a SoundScore of 3.6/5 in our lab testing. This invisible-in-ear device offers a discreet rechargeable design, though its acoustic performance shows notable strengths and weaknesses compared to alternatives in its price range. In our testing, the Eargo 5 demonstrates solid speech-in-quiet performance at 3.5/5, scoring 0.75 points above the OTC category average. Own-voice comfort also measures above average, which may appeal to users sensitive to occlusion effects. However, speech-in-noise performance is low at 1.4/5, and music streaming scores 0.0/5—significantly below the category average of 1.92/5. Users who prioritize phone streaming or frequently encounter noisy environments should consider these limitations. Feedback handling is strong in absolute terms at 4.2/5, though slightly below the category average of 4.54/5. The device uses closed sleeves for ear coupling in both initial and tuned configurations, with minimal score improvement from tuning (3.6 to 3.7/5). At this price point, competitors like the Lucid Tala (4.63/5) and Audicus Omni 2 (4.61/5) offer substantially higher overall sound performance. Budget-conscious shoppers may also find similar or better sound quality from lower-priced options like the Sony CRE-C10. The Eargo 5 may suit users who prioritize invisible cosmetics and quiet-environment listening over streaming and noise performance.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.